Connect with us
Prague Gaming & TECH Summit 2024

Artificial Intelligence

Transplantation Market Size is projected to reach USD 29.73 Billion by 2030, growing at a CAGR of 9.55 %: Straits Research

Published

on

New York, United States, Aug. 11, 2022 (GLOBE NEWSWIRE) — The global increase in the demand for organs for transplant can be attributed to increasing incidences of acute diseases, which in turn results in an increase in the number of organ failures. The growing demand for novel tissue transplantation products and organ transplantation for the treatment of organ failure is a major factor contributing to the growth of the market.

Get a Free Sample Copy of This Report @ https://straitsresearch.com/report/transplantation-market/request-sample

Technological Advancements in Organ Transplant Methods to Drive the Transplantation Market

Advanced technologies have led to an evolution in organ transplantation techniques and procedures, which is expected to propel market growth. Novel and improved transplantation products, including tissue products, tissue typing technology, and surgical medical instruments can be attributed to market expansion. Technological advancements in the field of 3D bioprinting are also boosting the adoption of organ transplantation.

The continuous shortage of organ donors and the increasing number of patients on the waiting list for organ transplants have increased the demand for 3D bioprinting. These techniques are used to create customized prosthetics, fabricate tissue, and to support transplantation through synthetic models. Therefore, the introduction of such advanced techniques has led to the growth of the transplantation market, driving the number of organ transplant procedures globally.

Regional Analysis

North America and Asia-Pacific are the two important regions of the transplantation market. The North American transplantation market was valued at USD 5,246.3 million in 2021 and is expected to grow at a CAGR of 8.2% during the forecast period, to reach an expected value of USD 10,707.8 million in 2030. In North America, the US dominates the market owing to a large patient pool, favourable reimbursement policies, and an increase in the number of organ transplantation procedures.

The Asia-Pacific transplantation market was valued at USD 2,661.9 million in 2021 and is expected to grow at a CAGR of 11.25% during the forecast period, to reach an expected value of USD 6,485.1 million in 2030. Asia-Pacific comprises growing economies such as Japan, China, and India. These countries have a sizable massive population and a high prevalence of chronic diseases.

Report Scope

Report Metric Details
Market Size 29.7 billion  by 2030
CAGR 9.55% (2022-2030)
Historical Data 2019-2020
Base Year 2021
Forecast Period 2022-2030
Forecast Units Value (USD Billion )
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Segments Covered Product Type,  Applications, End-Users
Geographies Covered North America, Europe, Asia-Pacific, LAME and Rest of the World
Key Companies Profiled/Vendors AbbVie, Inc., Arthrex Inc., Zimmer Biomet, Medtronic, Novartis AG, Stryker, 21st Century Medicine, BioLife Solutions Inc, Teva Pharmaceuticals, Veloxis Pharmaceuticals
Key Market Opportunities Artificial Organs and Immunosuppressive Drugs to Create New Opportunities for the Transplantation Market
Key Market Drivers Inflating Incidences of Organ Failure
Development of Tissue Banks
Technological Advancements in Organ Transplant Methods

Buy Now Full Report @ https://straitsresearch.com/buy-now/transplantation-market

Impact of COVID-19

The fast spread of coronavirus has plunged the global healthcare industry into disarray. Since a significant proportion of coronavirus patients were hospitalized in medical centers, governing bodies were obliged to reschedule optional and non-urgent operations in hospitals and ambulatory care centers. The pandemic also caused a drop in organ transplant surgery enrolment worldwide.

The decrease in the number of transplantation and organ donation procedures is mainly because of factors such as unavailability of resources, engaged surgeons, lockdown, and travel restrictions. Patients with positive reports for COVID-19 were refrained from donating organs due to the possibility of infection. Furthermore, another major concern influencing transplantation operations was the possibility of immunosuppressant drug interactions with COVID-19 therapy agents, which had led to a significant number of organ failures from graft donors.

Market Recovery Timeline

Markets have experienced massive losses as a result of the pandemic, plunging the world into a financial crisis. The COVID-19 pandemic has resulted in significant changes, and the pandemic’s long-term effect is concerning. According to the World Economic Forum, recovering from the COVID-19 problem could take up to three years. Nonetheless, the transplantation business is expected to gain traction following a major decline in coronavirus disease caseloads.

Key Highlights

  • Based on product, the transplantation market is segmented into immunosuppressive drugs, tissue products, and preservation solutions. The tissue products market was valued at USD 7,528.3 million in 2021 and is expected to grow at a CAGR of 9.2% from 2022 to 2030 to reach an estimated value of USD 16,691.2 million by 2030. The tissue products segment held the highest revenue in 2021.
  • Based on application, the transplantation market is segmented into tissue and organ transplantation. The tissue transplantation market was valued at USD 7,907.3 million in 2021 and is expected to grow at a CAGR of 9.7% to reach an estimated value of USD 18,267.0 million by 2030. 
  • Based on end-user, the transplantation market is segmented into hospitals, transplant centers, and others. The hospital segment was valued at USD 6,481.3 million in 2021 and is expected to grow at a CAGR of 9.1% to reach an estimated value of USD 14,251.9 million by 2030. The hospital segment held the highest market share due to increasing admissions of patients with organ failure. 

Get a Free Sample Copy of This Report @ https://straitsresearch.com/report/transplantation-market/request-sample

List of Key Players

  • AbbVie, Inc.
  • Arthrex, Inc.
  • Zimmer Biomet
  • Medtronic
  • Novartis AG
  • Stryker
  • 21st Century Medicine
  • BioLife Solutions, Inc
  • Teva Pharmaceuticals
  • Veloxis Pharmaceuticals

Global Transplantation Market: Segmentation

By Product Type

  • Immunosuppressive Drugs
  • Tissue Products
  • Preservation Solutions

By Application

  • Organ Transplantation
  • Tissue Transplantation

By End-Users

  • Hospitals
  • Transplant Centers
  • Others

By Regions

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • MEA

TABLE OF CONTENT

1          Introduction

1.1      Market Definition

1.2      Market Scope

2          Research Methodology

2.1      Primary Research

2.2      Research Methodology

2.3      Assumptions & Exclusions

2.4      Secondary Data Sources

3          Executive Summary

4          Market Overview

4.1      Report Segmentation & Scope

4.2      Value Chain Analysis: Transplantation Market

4.2.1  Vendor Matrix

4.3      Key Market Trends

4.3.1  Drivers

4.3.2  Restraints

4.3.3  Opportunities

4.4      Porter’s Five Forces Analysis

4.4.1  Bargaining Power of Suppliers

4.4.2  Bargaining Power of Buyers

4.4.3  Threat of Substitution

4.4.4  Threat of New Entrants

4.4.5  Competitive Rivalry

4.5      Environment & Regulatory Landscape

4.6      Forecast Factors & Relevance of Impact

4.7      Macro-Economic & Geopolitical Scenario

4.8      Parent Market Overview

4.9      Technology Landscape

4.10   Market Share Analysis

4.11   Potential Venture Analysis

4.12   Regional Price Trends

4.13   Raw Material Trends

4.14   Cost Structure Analysis

4.14.1            Labor Cost

4.14.2            Consumables

4.14.3            Maintenance Cost

4.15   Covid-19 Impact Analysis:

4.15.1            Pre and Post Covid-19 Market Scenario Analysis

4.15.2            Market Recovery Timeline and Challenge

4.15.3            Measures Taken by Top Players

4.15.4            Quarterly Market Revenue and Growth Forecast till 2021

4.15.4.1        North America

4.15.4.2        Europe

4.15.4.3        Asia-Pacific

4.15.4.4        Central and South America and the Caribbean

4.15.4.5        The Middle East and Africa

5           Product Type Overview

5.1      Introduction

5.1.1  Market Size & Forecast (Value & Volume)

5.2      Immunosuppressive drugs

5.2.1  Market Size & Forecast (Value & Volume)

5.3      Tissue products

5.3.1  Market Size & Forecast (Value & Volume)

5.4      Preservation solutions

5.4.1  Market Size & Forecast (Value & Volume)

6           Application Overview

6.1      Introduction

6.1.1  Market Size & Forecast (Value & Volume)

6.2      Organ transplantation

6.2.1  Market Size & Forecast (Value & Volume)

6.3      Tissue transplantation

6.3.1  Market Size & Forecast (Value & Volume)

7          End User Overview

7.1      Introduction

7.1.1  Market Size & Forecast (Value & Volume)

7.2      Hospitals

7.2.1  Market Size & Forecast (Value & Volume)

7.3      Transplant Centers

7.3.1  Market Size & Forecast (Value & Volume)

7.4      Others

7.4.1  Market Size & Forecast (Value & Volume)

8           Regional Overview

8.1      Introduction

8.1.1  Market Size & Forecast (Value & Volume)

8.2      North America

8.2.1  Economic Overview

8.2.2  Market Scenario

8.2.3  U.S.

8.2.4  Canada

8.2.5  Mexico

8.3      Central and South America and the Caribbean

8.3.1  Economic Overview

8.3.2  Market Scenario

8.3.3  Brazil

8.3.4  Argentina

8.3.5  Colombia

8.3.6  Rest of Central and South America and the Caribbean

8.4      Europe

8.4.1  Economic Overview

8.4.2  Market Scenario

8.4.3  Germany

8.4.4  France

8.4.5  The U.K.

8.4.6  Italy

8.4.7  The Rest Of Europe

8.5      Asia-Pacific (APAC)

8.5.1  Economic Overview

8.5.2  Market Scenario

8.5.3  China

8.5.4  Japan

8.5.5  India

8.5.6  Australia

8.5.7  South Korea

8.5.8  Rest Of APAC

8.6      Middle East

8.6.1  Economic Overview

8.6.2  Market Scenario

8.6.3  South Arabia

8.6.4  The UAE

8.6.5  Qatar

8.6.6  Oman

8.6.7  Turkey

8.6.8  The Rest Of Middle East

8.7      Africa

8.7.1  Economic Overview

8.7.2  Market Scenario

8.7.3  Nigeria

8.7.4  South Africa

8.7.5  The Rest Of Africa

9          Competitive Landscape — Manufacturers & Suppliers

9.1      Competition Dashboard

9.2      Industry Structure

9.3      AbbVie, Inc.

9.3.1  Business Overview

9.3.2  Financial Performance

9.3.3  Recent Developments

9.3.4  Portfolio

9.4      Arthrex, Inc.

9.5      Zimmer Biomet

9.6      Medtronic

9.7      Novartis AG

9.8      Stryker

9.9      21st Century Medicine

9.10   BioLife Solutions, Inc

9.11   Teva Pharmaceuticals

9.12   Veloxis Pharmaceuticals

10       Conclusion & Recommendation

11       Acronyms & Abbreviations

Table of Content and Figure @ https://straitsresearch.com/report/transplantation-market/toc

Market News

  • In May 2020, AbbVie, Inc. completed the acquisition of Allergan plc. This transaction expanded and diversified the company’s market share and portfolio in different therapeutic areas: Hematologic Oncology, Neuroscience, & Allergan Aesthetics.

News Media

Transplantation Market to Expand at a Healthy CAGR During Forecast Period

Asia Pacific to Account for a Prominent Myasthenia Gravis Treatment Market Share During the Forecast Period, Backed by Improvements in Healthcare Reforms

Have a Look at the Related Research Report               

Transplant Diagnostics MarketInformation by Technology (Molecular Assay), Component, Transplant (Solid Organ Transplantation), Application, End-Use, and Region — Forecast till 2029

Renal Replacement Therapy Market: Information by Product (Consumables, Systems), Modalities (Slow Continuous Ultra Filtration), and Region — Forecast till 2029

Smart Orthopedic Implants Market: Information by Application (Knee, Hip), Components (Electronic Components), Implants Procedures (Total Replacement), and Region — Forecast till 2030

About Straits Research Pvt. Ltd.

StraitsResearch is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision-makers. Straits Research Pvt. Ltd. provides actionable market research data, especially designed and presented for decision making and ROI.

Whether you are looking at business sectors in the next town or crosswise over continents, we understand the significance of being acquainted with the client’s purchase. We overcome our clients’ issues by recognizing and deciphering the target group and generating leads with utmost precision. We seek to collaborate with our clients to deliver a broad spectrum of results through a blend of market and business research approaches.

                                                                          

For more information on your target market, please contact us below:

Phone: +1 646 480 7505 (the U.S.)

+91 8087085354 (APAC)             

+44 208 068 9665 (the U.K.)

Email: [email protected]

Follow Us: LinkedIn | Facebook | Instagram | Twitter

GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Artificial Intelligence

Gilbarco Veeder-Root champions fuel efficiency, clean fuels and diesel rebate solutions in mining

Published

on

gilbarco-veeder-root-champions-fuel-efficiency,-clean-fuels-and-diesel-rebate-solutions-in-mining

JOHANNESBURG, March 28, 2024 /PRNewswire/ — Global leader in technology solutions OEM Gilbarco Veeder-Root (GVR) is dedicated to enhancing operational performance by delivering comprehensive end-to-end wetstock, industrial, mining, and business-to-business solutions, all tailored to meet the specific needs of the customer.

 
 
By encompassing every aspect of mining operations, GVR commercial and industrial Middle East and Africa director Westtar Kapito says, “the company is setting new benchmarks for fuel efficiency, safety and sustainability within the mining industry”.
As part of a holistic approach to mining excellence, Kapito explains that Gilbarco’s integrated fuel and fleet management technology solutions are designed to address the multifaceted challenges of the mining industry.
Some of these facets include wetstock control, equipment maintenance and management, fleet management and automation, compliance monitoring and environmental sustainability, as well as driving productivity and profitability through innovation.
In addition, the introduction of Gilbarco’s clean fuel solution exemplifies the company’s commitment to maintaining equipment integrity and performance.
This technology, GVR says, monitors in real-time the status of up to 16 “clean fuels” key performance matrices, thereby ensuring that dirty fuel is flagged and not transferred into mining equipment which would affect engines and injectors and thus lower productivity.
Gilbarco’s comprehensive site automation solutions empower mining companies with critical data analytic insights, facilitating efficient monitoring and management of fleet and fuel inventory. Gilbarco’s dataFLEX360 platform plays a pivotal role, offering near real-time reporting and analytics to drive informed decision-making and operational agility.
dataFLEX360 is a Web-based, cloud-hosted strategic operational insights platform. The system ensures accurate, reliable and relevant reporting of all fuel, fleet and asset transactions, and provides for proactive corrective measures to reduce complex reporting and gives a consolidated and comprehensive view across all sites and assets.
With reconciliations at its core, dataFLEX360 provides solution accuracy on operational data.
Integral to the company’s solutions is compliance with Global Industry Standards and environmental stewardship, from leak detection to vapour recovery and clean fuel technologies. Gilbarco’s products are designed to ensure compliance and minimise the carbon footprint of mining operations.
Additionally, through the company’s innovative telematics technology and the data generated, it can systematically and seamlessly generate South African Revenue Services- (SARS-) compliant fuel rebate reports for any selected tax period.  
GVR’s technology provides a full audit trail required for eligibility for SARS rebates, and its reporting platform simplifies logbook and data gathering required, enabling successful rebate claims and return on investment.
Photo – https://mma.prnewswire.com/media/2373644/Gilbarco_Veeder_Roots_MEA.jpg

View original content:https://www.prnewswire.co.uk/news-releases/gilbarco-veeder-root-champions-fuel-efficiency-clean-fuels-and-diesel-rebate-solutions-in-mining-302102415.html

Continue Reading

Artificial Intelligence

Invoca Wins CX Today Award for Best Conversational Intelligence Solution of 2024; Launches European Data Centre and Adds UK Sales Leader

Published

on

invoca-wins-cx-today-award-for-best-conversational-intelligence-solution-of-2024;-launches-european-data-centre-and-adds-uk-sales-leader

CX Today recognises Invoca as the foremost visionary in the Conversational Intelligence category. Additionally, expands its European presence with a new Data Centre and the appointment of Duncan MacPherson as UK Director of Sales.
LONDON, March 28, 2024 /PRNewswire/ — Invoca, the leading revenue execution platform for revenue teams, has won the CX Today Award for ‘Best Conversational Intelligence Solution’ of 2024. CX Today, the leading international news publication honouring excellence in CX technology, hosted the CX Awards to honour excellence in CX leadership, technology innovation, and industry success.

“Invoca’s exceptional work in conversational intelligence has helped push the category forward, and we are thrilled to see their accomplishments acknowledged at CX Awards 2024,” said Charlie Mitchell, Senior Editor at CX Today and host of the awards.
The award recognises Invoca’s strength in empowering revenue teams across marketing, contact centre sales, and customer experience to enhance buying experiences, increase high-value leads, and boost revenue. For businesses that acquire customers over the phone, Invoca enables these digital marketing and contact centre teams to collaborate to drive revenue growth. Invoca stands out for capturing deep insights from consumer calls and digital interactions and ingesting revenue driven by calls and other metadata from CRM and contact centre solutions, making Invoca the source of truth for consumer engagements.
“We’re thrilled to be named the Best Conversational Intelligence Solution of 2024 by CX Today as we highlight our longstanding vision to help brands acquire customers and grow their revenue,” said Gregg Johnson, CEO of Invoca. “As AI pioneers in this space, having first introduced our broad base of patented AI technologies in 2015, artificial intelligence and machine learning are core to helping companies improve the customer experience and connect the buyer journey.”
The CX Awards’ judging panel, including Dan Miller, Lead Analyst at Opus Research, reviewed hundreds of applications for their organisation’s ability to improve overall customer experience through innovation and high-impact features.
“Invoca continues to demonstrate that they are a clear leader in conversational intelligence AI. We recognised Invoca for their ability to employ a sophisticated blend of AI technologies — including patented machine learning, generative AI, voice biometrics, and deep learning neural networks, to drive revenue,” said Dan Miller, CX Awards judge and Lead Analyst at Opus Research.
Invoca Launches New European Platform and Data Centre Amid U.K. Sales Leadership Expansion
Invoca continues to reinforce its commitment to maintaining data excellence with unwavering reliability and strict adherence to security standards. Protecting customer data privacy remains a top priority, particularly given the heightened concerns surrounding security and privacy. Invoca’s new European platform and localised data centres support its growing customer base by ensuring all customers can adhere to the highest level of enterprise-grade data privacy, and GDPR compliance standards. Invoca’s powerful EU-based infrastructure enables its customers to recreate the same Invoca experience using the full feature suite while maintaining the highest standards of quality.
Invoca has also welcomed Duncan MacPherson as UK Director of Sales. MacPherson brings extensive experience with large companies and start-ups selling customer engagement solutions. This is part of an overall expansion in the UK market, which includes hiring a localised sales and customer success team, sales development, and marketing support.
More Information:
See the results you can get with Invoca’s award-winning conversation intelligence: https://www.invoca.com/customersInvoca’s GDPR Compliance: Everything You Need to Know: https://www.invoca.com/blog/invocas-gdpr-compliance-everything-you-need-to-knowWatch the CX Today Awards winners revealed on demand: www.cxtoday.com/cxawardsJoin Invoca’s talented team today: https://www.invoca.com/company/careersAbout InvocaInvoca is a revenue execution platform that connects marketing and sales teams to help them track and optimise the buying journey to drive more revenue. By using a comprehensive revenue execution platform with deep integrations with leading technology platforms, revenue teams can better connect their paid media investments directly to revenue, improve digital engagement, and deliver the best buyer experiences to drive more sales. With Invoca, top consumer brands, including AutoNation, DIRECTV, Mayo Clinic, Mutual of Omaha, and Verizon, experience unbelievable results powered by undeniable data. Invoca has raised $184M from leading venture capitalists, including Upfront Ventures, Accel, Silver Lake Waterman, H.I.G. Growth Partners, and Salesforce Ventures. For more information, visit www.invoca.com.
About CX AwardsHosted by CX Today, the awards ceremony has become the beacon of recognition for companies and professionals pushing the envelope in the CX technology sphere.
The CX Awards 2024 is here for its fourth year and is bigger and better than ever before! Winners of the 2023 awards included Vonage, Calabrio, and UJET and more. Then, the ceremony included exclusive streams from our people winners, Jay Patel from Webex and Kimberley Wood from Ultimate. Yet, this year’s event featured many more CX leaders who shared their unique takes on the space.
Photo – https://mma.prnewswire.com/media/2373968/Invoca___CXToday___PR_Newswire_Image___2700x1080___v_1.jpg

View original content:https://www.prnewswire.co.uk/news-releases/invoca-wins-cx-today-award-for-best-conversational-intelligence-solution-of-2024-launches-european-data-centre-and-adds-uk-sales-leader-302102358.html

Continue Reading

Artificial Intelligence

ASC Achieves Certification for Webex Calling

Published

on

asc-achieves-certification-for-webex-calling

ASC announces compliance recording and AI-driven analytics tool for Webex Calling
HÖSBACH, Germany, March 28, 2024 /PRNewswire/ — ASC Technologies, a leading provider of comprehensive recording and analytics tools, announces its successful certification for Webex Calling with Webex by Cisco, a leading provider of collaboration technologies powering hybrid work and customer experience. This certification distinguishes ASC as one of the few global vendors who are authorized to provide record capabilities for Webex Calling communications. This capability is essential for organizations in regulated industries that must adhere to strict compliance standards.

A key benefit of the ASC solution is the simple and fast configuration in the Webex Control Hub, which ensures a high level of user-friendliness. In addition, ASC enables the migration of on-premise solutions to the cloud by seamlessly transferring recordings to the cloud environment. This step enables organizations to accelerate their digital transformation and take advantage of cloud-based services. In addition, AI-driven analytics, powered by ASC’s solutions, help organizations gain a comprehensive view of their communications, enrich customer relationships, and streamline compliance and risk management processes.
“As a stable company that has been established in the market for 60 years, we see the certification for Webex Calling not only as a confirmation of our technological expertise, but also as a promise to our customers and partners,” says Dr. Gerald Kromer, CEO of ASC. “We are committed to providing innovative and reliable solutions that meet the demands of today’s communications technologies while ensuring our customers’ compliance requirements.”
This certification is a further milestone in ASC’s successful partnership with Cisco, which has already existed for 20 years. ASC will be exhibiting at Enterprise Connect in Gaylord Palms, and Cisco Live in Las Vegas, showcasing its innovative recording and analytics solutions and demonstrating the results of its collaboration with Cisco. These events offer a glimpse into how ASC’s solutions drive efficiency and insight.
About ASC
ASC is a worldwide leading provider of software and cloud solutions in the field of omni-channel recording, quality management, and analytics. Among our target groups are all companies that record their communications, especially financial service providers, contact centers, and public safety organizations. We offer solutions for recording as well as AI-based analysis and evaluation of all communications – with full flexibility as a cloud service, on-premise or as a hybrid solution. Headquartered in Germany with subsidiaries in 14 countries and experienced system integration partners in over 60 countries, ASC is the #1 Europe-based player in its industry.
About Webex by Cisco
Webex is a leading provider of cloud-based collaboration solutions which includes video meetings, calling, messaging, events, customer experience solutions like contact center and purpose-built collaboration devices. At Webex, we start with people and their experiences first. This focus on delivering inclusive collaboration experiences fuels our innovation, which leverages AI and Machine Learning, to remove the barriers of geography, language, personality, and familiarity with technology. Our solutions are underpinned with security and privacy by design. We work with the world’s leading business and productivity apps – delivered through a single application and interface. Learn more at webex.com.
Logo: https://mma.prnewswire.com/media/2003160/ASC_Logo.jpg
 

View original content:https://www.prnewswire.co.uk/news-releases/asc-achieves-certification-for-webex-calling-302102352.html

Continue Reading

Trending